Literature DB >> 11403851

A P450 BM-3 mutant hydroxylates alkanes, cycloalkanes, arenes and heteroarenes.

D Appel1, S Lutz-Wahl, P Fischer, U Schwaneberg, R D Schmid.   

Abstract

P450 monooxygenases from microorganisms, similar to those of eukaryotic mitochondria, display a rather narrow substrate specificity. For native P450 BM-3, no other substrates than fatty acids or an indolyl-fatty acid derivative have been reported (Li, Q.S., Schwaneberg, U., Fischer, P., Schmid, R.D., 2000. Directed evolution of the fatty-acid hydroxylase P450BM-3 into an indole-hydroxylating catalyst. Chem. Eur. J. 6 (9), 1531-1536). Engineering the substrate specificity of Bacillus megaterium cytochrome P-450 BM3: hydroxylation of alkyl trimethylammonium compounds. Biochem. J. 327, 537-544). We thus were quite surprised to observe, in the course of our investigations on the rational evolution of this enzyme towards mutants, capable of hydroxylating shorter-chain fatty acids, that a triple mutant P450 BM-3 (Phe87Val, Leu188-Gln, Ala74Gly, BM-3 mutant) could efficiently hydroxylate indole, leading to the formation of indigo and indirubin (Li, Q.S., Schwaneberg, U., Fischer, P., Schmid, R.D., 2000. Directed evolution of the fatty-acid hydroxylase P450BM-3 into an indole-hydroxylating catalyst. Chem. Eur. J. 6 (9), 1531-1536). Indole is not oxidized by the wild-type enzyme; it lacks the carboxylate group by which the proper fatty acid substrates are supposed to be bound at the active site of the native enzyme, via hydrogen bonds to the charged amino acid residues Arg47 and Tyr51. Our attempts to predict the putative binding mode of indole to P450 BM-3 or the triple mutant by molecular dynamics simulations did not provide any useful clue. Encouraged by the unexpected activity of the triple mutant towards indole, we investigated in a preliminary, but systematic manner several alkanes, alicyclic, aromatic, and heterocyclic compounds, all of which are unaffected by the native enzyme, for their potential as substrates. We here report that this triple mutant indeed is capable to hydroxylate a respectable range of other substrates, all of which bear little or no resemblance to the fatty acid substrates of the native enzyme.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11403851     DOI: 10.1016/s0168-1656(01)00249-8

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  10 in total

Review 1.  Laboratory-directed protein evolution.

Authors:  Ling Yuan; Itzhak Kurek; James English; Robert Keenan
Journal:  Microbiol Mol Biol Rev       Date:  2005-09       Impact factor: 11.056

2.  Stabilization of the Reductase Domain in the Catalytically Self-Sufficient Cytochrome P450BM3 by Consensus-Guided Mutagenesis.

Authors:  Gloria Saab-Rincón; Hanan Alwaseem; Valeria Guzmán-Luna; Leticia Olvera; Rudi Fasan
Journal:  Chembiochem       Date:  2018-02-12       Impact factor: 3.164

3.  Enantioselective alpha-hydroxylation of 2-arylacetic acid derivatives and buspirone catalyzed by engineered cytochrome P450 BM-3.

Authors:  Marco Landwehr; Lisa Hochrein; Christopher R Otey; Alex Kasrayan; Jan-E Bäckvall; Frances H Arnold
Journal:  J Am Chem Soc       Date:  2006-05-10       Impact factor: 15.419

4.  Structural evidence: a single charged residue affects substrate binding in cytochrome P450 BM-3.

Authors:  Jaclyn Catalano; Kianoush Sadre-Bazzaz; Gabriele A Amodeo; Liang Tong; Ann McDermott
Journal:  Biochemistry       Date:  2013-09-16       Impact factor: 3.162

5.  Combining substrate dynamics, binding statistics, and energy barriers to rationalize regioselective hydroxylation of octane and lauric acid by CYP102A1 and mutants.

Authors:  K Anton Feenstra; Eugene B Starikov; Vlada B Urlacher; Jan N M Commandeur; Nico P E Vermeulen
Journal:  Protein Sci       Date:  2007-03       Impact factor: 6.725

6.  A panel of cytochrome P450 BM3 variants to produce drug metabolites and diversify lead compounds.

Authors:  Andrew M Sawayama; Michael M Y Chen; Palaniappan Kulanthaivel; Ming-Shang Kuo; Horst Hemmerle; Frances H Arnold
Journal:  Chemistry       Date:  2009-11-02       Impact factor: 5.236

7.  How Do Perfluorinated Alkanoic Acids Elicit Cytochrome P450 to Catalyze Methane Hydroxylation? An MD and QM/MM Study.

Authors:  Chunsen Li; Sason Shaik
Journal:  RSC Adv       Date:  2013-03-07       Impact factor: 3.361

8.  Scanning chimeragenesis: the approach used to change the substrate selectivity of fatty acid monooxygenase CYP102A1 to that of terpene omega-hydroxylase CYP4C7.

Authors:  Chiung-Kuang J Chen; Robert E Berry; Tatjana Kh Shokhireva; Marat B Murataliev; Hongjung Zhang; F Ann Walker
Journal:  J Biol Inorg Chem       Date:  2009-08-30       Impact factor: 3.358

9.  Hydroxylation of diverse flavonoids by CYP450 BM3 variants: biosynthesis of eriodictyol from naringenin in whole cells and its biological activities.

Authors:  Luan Luong Chu; Ramesh Prasad Pandey; Narae Jung; Hye Jin Jung; Eun-Hee Kim; Jae Kyung Sohng
Journal:  Microb Cell Fact       Date:  2016-08-05       Impact factor: 5.328

10.  Structural insights into diversity and n-alkane biodegradation mechanisms of alkane hydroxylases.

Authors:  Yurui Ji; Guannan Mao; Yingying Wang; Mark Bartlam
Journal:  Front Microbiol       Date:  2013-03-21       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.